The Economics of Genomic Medicine Workshop Summary (2013) / Chapter Skim
Currently Skimming:
1 Introduction and Overview
1 Introduction and Overview
Pages 1-8
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
This has created a tension between experts who contend that using this information is premature and those who believe that having such information will empower health care providers and patients to make proactive decisions regarding lifestyle and treatment options. In addition, some stakeholders are concerned that genomic technologies will add costs to the health care system without providing commensurate benefits, and others think that health care costs could be reduced by identifying unnecessary or ineffective treatments.
|
From page 2... ...
To understand better the health economic issues that may arise in the course of integrating genomic data into health care, the Roundtable on Translating Genomic-Based Research for Health hosted a workshop in Washington, DC, on July 17–18, 2012, that brought together economists, regulators, payers, biomedical researchers, patients, providers, and other stakeholders to discuss the many factors that may influence this implementation. The workshop was one of a series that the roundtable has held on this topic, but it was the first focused specifically on economic issues.
|
From page 3... ...
The first panel consisted of a clinician, a futurist, and a patient, who talked about how having genomic information could affect the choices, attitudes, and needs of stakeholders throughout the health care system. The second panel
|
From page 4... ...
The infrastructure needs to be developed to measure outcomes related to economic factors along with standard health outcomes, not just for genomics but across the health care system. For example, better and quicker
|
From page 5... ...
Behavioral research could determine if and how genomic information modifies the behavior of patients and health care providers, which is particularly important because this behavior will be a major driver of costs, said Feero. Also new methods are needed to increase participation in clinical trials, including participation of underrepresented subpopulations.
|
From page 6... ...
However, it is important to remember that this issue is not specific to genomics. Finally, asked Feero, in a world of stable or declining resources, do accountable care organizations provide a model for producing more efficient health care using genomic technologies?
|
From page 7... ...
INTRODUCTION AND OVERVIEW 7 in health care, economic analyses encompass issues that range far beyond costs and benefits to complex issues of regulation, ethics, and equity, as the above themes demonstrate. Many different sources of information will need to be brought together efficiently to enable informed decision making and to determine how to move forward with integrating genomic medicine in a way that maximizes patient benefit while at the same time making the most economic sense.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.